PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity.
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
PU.1 is a B-cell- and macrophage-specific transcription factor. By an electrophoretic mobility shift assay and dimethyl sulfate methylation interference assays, we show that PU.1 binds to DNA sequences within the immunoglobulin kappa 3' enhancer (kappa E3'). Binding of PU.1 to the kappa E3' enhancer assists the binding of a second tissue-restricted factor, NF-EM5, to an adjacent site. Binding of NF-EM5 to kappa E3' DNA sequences requires protein-protein interaction with PU.1 as well as specific protein-DNA interactions. This is the first known instance of PU.1 interacting with another cellular protein. NF-EM5 does not cofractionate with PU.1, suggesting that it is a distinct protein and is not a posttranslational modification of PU.1. UV-crosslinking studies and elution from sodium dodecyl sulfate-polyacrylamide gels indicate that NF-EM5 is a protein of approximately 46 kDa. Site-directed mutagenesis studies of the PU.1- and EM5-binding sites indicate that these sites play important roles in kappa E3' enhancer activity. By using a series of PU.1 deletion constructs, we have identified a region in PU.1 that is necessary for interaction with NF-EM5. This segment encompasses a 43-amino-acid region with PEST sequence homology, i.e., one that is rich in proline (P), glutamic acid (E), serine (S), and threonine (T).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,260
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Gorman, C. M., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,830
Site-directed mutagenesis by overlap extension using the polymerase chain reaction
Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K., & Pease, L. R. (1989) · Gene · doi:10.1016/0378-1119(89)90358-2 · Cited by 7,399 · cited 1×
“was generated by overlap extension by using the polymerase chain reaction (16).”
MethodThe Leucine Zipper: A Hypothetical Structure Common to a New Class of DNA Binding Proteins
Landschulz, W. H., Johnson, P. F., & McKnight, S. L. (1988) · Science · doi:10.1126/science.3289117 · Cited by 3,443
Transcriptional Regulation in Mammalian Cells by Sequence-Specific DNA Binding Proteins
Mitchell, P. J., & Tjian, R. (1989) · Science · doi:10.1126/science.2667136 · Cited by 3,114 · cited 2×
“Several major groups which include zinc finger domains, homeodomains, and basic region domains have been identified (9, 20, 29).”
BackgroundMurre, C., McCaw, P. S., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90682-x · Cited by 2,635 · cited 7×
“PU.1 does not contain sequences homologous to known dimerization domains (leucine zipper and HLH), and thus far there have been no reports of PU.1 interacting with other proteins.”
BackgroundInfluentialAmino Acid Sequences Common to Rapidly Degraded Proteins: The PEST Hypothesis
Rogers, S., Wells, R., & Rechsteiner, M. (1986) · Science · doi:10.1126/science.2876518 · Cited by 2,537 · cited 2×
“Regions rich in these amino acids have been denoted PEST regions, and they may be involved in degradation of intracellular proteins (37).”
BackgroundThe protein Id: A negative regulator of helix-loop-helix DNA binding proteins
Benezra, R., Davis, R. L., Lockshon, D., Turner, D. L., & Weintraub, H. (1990) · Cell · doi:10.1016/0092-8674(90)90214-y · Cited by 2,238 · cited 1×
“Thus, mammalian muscle differentiation and the Drosophila sensory organ patterning pathways can be greatly influenced by the presence of certain HLH dimerization partners (3, 8, 10).”
BackgroundHow eukaryotic transcriptional activators work
Ptashne, M. (1988) · Nature · doi:10.1038/335683a0 · Cited by 1,825
Murre, C., McCaw, P. S., Vaessin, H., Caudy, M., Jan, L. Y., Jan, Y. N., Cabrera, C. V., Buskin, J. N., Hauschka, S. D., Lassar, A. B., et al. (1989) · Cell · doi:10.1016/0092-8674(89)90434-0 · Cited by 1,815
Cited by
Items 101–200 of 352
Phosphorylation of E47 as a Potential Determinant of B-Cell-Specific Activity
Sloan, S. R., Shen, C.-P., McCarrick-Walmsley, R., & Kadesch, T. R. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.6900 · Cited by 98
Suppression of IL-12 Transcription in Macrophages Following Fcγ Receptor Ligation
Grazia Cappiello, M., Sutterwala, F. S., Trinchieri, G., Mosser, D. M., & Ma, X. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4498 · Cited by 98
“1 has been reported to affect its association with other transcription factors and its transcriptional activity (32).”
BackgroundA compilation of composite regulatory elements affecting gene transcription in vertebrates
Kel, O. V., Romaschenko, A. G., Kel, A. E., Wingender, E., & Kolchanov, N. A. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.20.4097 · Cited by 97
The Transcription Factor PU.1 is a Critical Regulator of Cellular Communication in the Immune System
Turkistany, S. A., & DeKoter, R. P. (2011) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-011-0147-9 · Cited by 96
Jundt, F., Kley, K., Anagnostopoulos, I., Schulze Pröbsting, K., Greiner, A., Mathas, S., Scheidereit, C., Wirth, T., Stein, H., & Dörken, B. (2002) · Blood · doi:10.1182/blood.v99.8.3060 · Cited by 99
The molecular basis of somatic hypermutation of immunoglobulin genes
Storb, U. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80059-8 · Cited by 98
Beuten, J., Gelfond, J., Franke, J. L., Weldon, K. S., Crandall, A. C., Johnson‐Pais, T. L., Thompson, I. M., & Leach, R. J. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0076 · Cited by 100
IFN Regulatory Factor 4 and 8 Promote Ig Light Chain κ Locus Activation in Pre-B Cell Development
Ma, S., Turetsky, A., Trinh, L., & Lu, R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7898 · Cited by 93
Watson, D. K., Fe, S., Thompson, D. L., Cheng, J., Testa, Papas, T. S., & Seth, A. K. (1992) · PubMed · Cited by 115
CD18 (beta 2 leukocyte integrin) promoter requires PU.1 transcription factor for myeloid activity.
Rosmarin, A. G., Caprio, D., Levy, R., & Simkevich, C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.801 · Cited by 94
Activation of Transcription by PU.1 Requires both Acidic and Glutamine Domains
Klemsz, M. J., & Maki, R. A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.1.390 · Cited by 93
Self-citationStütz, A. M., & Woisetschläger, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4383 · Cited by 77
“1 binding site in the Igk39 enhancer (19, 26, 27).”
BackgroundYamada, T., Kondoh, N., Matsumoto, M., Yoshida, M., Maekawa, A., & Oikawa, T. (1997) · Blood · doi:10.1182/blood.v89.4.1383 · Cited by 87
Wang, J.-M., Lai, M.-Z., & Yang-Yen, H.-F. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.6.1896-1909.2003 · Cited by 90
Loddenkemper, C., Anagnostopoulos, I., Hummel, M., Jöhrens‐Leder, K., Foss, H., Jundt, F., Wirth, T., Dörken, B., & Stein, H. (2003) · The Journal of Pathology · doi:10.1002/path.1485 · Cited by 104
“1 exerts its activity by interacting with the intronic Eμ enhancer [19] and the 3′ enhancer region of the Ig light chain genes [20].”
BackgroundThe development of functional B lymphocytes in conditional PU.1 knock-out mice
Polli, M., Dakic, A., Light, A., Wu, L., Tarlinton, D. M., & Nutt, S. L. (2005) · Blood · doi:10.1182/blood-2005-01-0283 · Cited by 90
The human beta 2 integrin CD18 promoter consists of two inverted Ets cis elements.
Böttinger, E. P., Shelley, C. S., Farokhzad, O. C., & Arnaout, M. A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.4.2604 · Cited by 89
Feinman, R., Qiu, W. Q., Pearse, R. N., Nikolajczyk, B. S., Sen, R., Sheffery, M., & Ravetch, J. V. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06696.x · Cited by 88
Marecki, S., Atchison, M. L., & Fenton, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2713 · Cited by 87
Self-citationScott, G. K., Daniel, J. C., Xiong, X., Maki, R. A., Kabat, D., & Benz, C. C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32098-7 · Cited by 87
Self-citationThe Ets-related transcription factor PU.1 immortalizes erythroblasts.
Schuetze, S., Stenberg, P. E., & Kabat, D. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.9.5670 · Cited by 87
PU.1 can participate in an active enhancer complex without its transcriptional activation domain
Pongubala, J. M. R., & Atchison, M. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.127 · Cited by 86
Self-citationMoulton, K. S., Semple, K., Wu, H., & Glass, C. K. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4408 · Cited by 86
Characterization of NERF, a Novel Transcription Factor Related to the Ets Factor ELF-1
Oettgen, P., Akbarali, Y., Boltax, J., Best, J., Kunsch, C., & Libermann, T. A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.5091 · Cited by 85
“) (45), HIV-2 LTR CD3R (50), HTLV-1 LTR (24), murine sarcoma virus (MSV) LTR (30), c-fos SRE (16), IL-2 NF-AT (81), T-cell receptor a (TCR a) enhancer Ta2 (35), Ig(k) 39 enhancer (68), IL-2B (81), and MHC class II promoter (43) sequences, are shown.”
Somatic Hypermutation of Immunoglobulin Genes is Linked to Transcription
Storb, U., Peters, A., Klotz, E., Kim, N., Shen, H. M., Kage, K., Rogerson, B. J., & Martin, T. E. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-71984-4_2 · Cited by 84
Himmelmann, A., Riva, A., Wilson, G. L., Lucas, B. P., Thevenin, C., & Kehrl, J. H. (1997) · Blood · doi:10.1182/blood.v90.10.3984 · Cited by 68
Suzuki, M., Yamada, T., Kihara-Negishi, F., Sakurai, T., & Oikawa, T. (2003) · Oncogene · doi:10.1038/sj.onc.1207182 · Cited by 87
Regulation of Immunoglobulin Light Chain Isotype Expression
Gorman, J. R., & Alt, F. W. (1998) · Advances in immunology · doi:10.1016/s0065-2776(08)60607-0 · Cited by 93
Shaffer, A. L., Peng, A., & Schlissel, M. S. (1997) · Immunity · doi:10.1016/s1074-7613(00)80420-3 · Cited by 83
Targeting IRF4 in autoimmune diseases
Xu, W., Pan, H., Ye, D., & Xu, Y. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.08.011 · Cited by 85
“IRF4 protein comprises a single polypeptide chain [9] that could be roughly split into three parts: a functional regulatory domain containing two transactivation domains (TAD) and regions required for ternary complex formation and auto-suppression [10], a highly conserved N-terminal DNA-binding domain (DBD), which is…”
BackgroundRoss, I. L., Yue, X., Ostrowski, M. C., & Hume, D. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.12.6662 · Cited by 79
A Two-Step Mechanism for Recruitment of Pip by PU.1
Perkel, J. M., & Atchison, M. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.241 · Cited by 77
“1 mutantsD7–30,D33–100,D1–117,D1–160,D119–160, and D245–272 were previously described (6).”
BackgroundMethodInfluentialSelf-citationSingh, H. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80053-7 · Cited by 88
Rosenbauer, F., Waring, J. F., Foerster, J., Wietstruk, M., Philipp, D., & Horak, I. (1999) · Blood · doi:10.1182/blood.v94.12.4274 · Cited by 76
PU.1 but not ets-2 is essential for macrophage development from embryonic stem cells
Henkel, G., McKercher, Sr., Yamamoto, H., Anderson, K., Oshima, R., & Maki, R. (1996) · Blood · doi:10.1182/blood.v88.8.2917.bloodjournal8882917 · Cited by 76
Self-citationVan Lint, C., Ghysdael, J., Paras, P., Burny, A., & Verdin, E. (1994) · Journal of Virology · doi:10.1128/jvi.68.4.2632-2648.1994 · Cited by 78
“1/Spi-1 binding sites are present in a large number of B-lymphoid-, myeloid-, and erythroid cell-specific transcriptional elements, such as the enhancers of two SV40 variants (66), the promoter of the major histocompatibility complex class II gene I-AP (20), the mouse immunoglobulin K3' enhancer (67), the promoter of…”
BackgroundThe Myeloid-Cell-Specific c-fes Promoter Is Regulated by Sp1, PU.1, and a Novel Transcription Factor
Heydemann, A., Juang, G., Hennessy, K., S. Parmacek, M., & Celeste Simon, M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1676 · Cited by 70
“1 has been demonstrated to form a complex with the B-cell factor NF-EM5 to activate the immunoglobulin k and l 39 enhancers (24).”
BackgroundGontarek, R. R., McNally, M. T., & BEEMON, K. L. (1993) · Genes & Development · doi:10.1101/gad.7.10.1926 · Cited by 86
Inhibition of CBP-Mediated Protein Acetylation by the Ets Family Oncoprotein PU.1
Hong, W., Kim, A. Y., Ky, S., Rakowski, C., Seo, S.-B., Chakravarti, D., Atchison, M., & Blobel, G. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3729-3743.2002 · Cited by 74
“1 constructs have been described previously (58, 60, 61).”
MethodSelf-citationGupta, P., Gurudutta, G. U., Saluja, D., & Tripathi, R. P. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00757.x · Cited by 74
“In case of the B-lymphoid genes such as Ig heavy chain ( ) [34], Ig light chains ( and ) [35, 36], mb- (Ig ) [37], B29 (Ig ) [38] and Ig-J chain [33], the binding of PU.”
BackgroundPU.1/Interferon Regulatory Factor Interactions; Mechanisms of Transcriptional Regulation
Marecki, S., & Fenton, M. J. (2000) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:33:2:127 · Cited by 74
“As noted above, PU.1 can also interact with the IRF family members ICSBP and IRF-4 (6,7,17).”
BackgroundInfluentialThe NIMA-family kinase Nek3 regulates microtubule acetylation in neurons
Chang, J., Baloh, R. H., & Milbrandt, J. (2009) · Journal of Cell Science · doi:10.1242/jcs.048975 · Cited by 87
“, 1986); however, it is now known to also mediate protein-protein interactions (Pongubala et al., 1992; Zhang et al., 2007).”
BackgroundMyeloid-specific gene expression
Clarke, S., & Gordon, S. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.63.2.153 · Cited by 81
Role of Transcription Factors C/EBPa and PU.1 in Normal Hematopoiesis and Leukemia
Koschmieder, S., Rosenbauer, F., Steidl, U., Owens, B. M., & Tenen, D. G. (2005) · International Journal of Hematology · doi:10.1532/ijh97.05051 · Cited by 72
“For example, IRF-4/Pip, a member of the interferon regulatory factor (IRF) family, which is expressed in lymphocytes and at lower levels in macrophages, synergizes with PU.1 to transactivate an element in the immunoglobulin light chain enhancers by forming a ternary complex with PU.1 on a composite IRF/ETS-binding sit…”
BackgroundMonocyte maturation controls expression of equine infectious anemia virus
Maury, W. (1994) · Journal of Virology · doi:10.1128/jvi.68.10.6270-6279.1994 · Cited by 72
PU.1 Is Essential for p47 Promoter Activity in Myeloid Cells
Li, S.-L., Valente, A. J., Zhao, S.-J., & Clark, R. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17802 · Cited by 72
PU.1 cooperates with IRF4 and IRF8 to suppress pre-B-cell leukemia
Pang, S. H. M., Minnich, M., Gangatirkar, P., Zheng, Z., Ebert, A., Song, G., Dickins, R. A., Corcoran, L. M., Mullighan, C. G., Busslinger, M., et al. (2016) · Leukemia · doi:10.1038/leu.2016.27 · Cited by 69
Hematopoietic lineage commitment: Role of transcription factors
Kehrl, J. H. (1995) · STEM CELLS · doi:10.1002/stem.5530130304 · Cited by 69
Lazorchak, A. S., Schlissel, M. S., & Zhuang, Y. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.3.810-821.2006 · Cited by 68
Regulation of activation and recombination of the murine Igκ locus
Schlissel, M. S. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00157.x · Cited by 72
Review: The Role of IRF-4 in Transcriptional Regulation
Marecki, S., & Fenton, M. J. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452737 · Cited by 67
“IRF-4 was initially characterized as a transcriptional activator, (8) where this function was linked to a physical interaction with PU.1 while bound to a composite PU.1/IRF element pres-ent in the Ig k light chain enhancer in B cells.”
Nagulapalli, S., & Atchison, M. L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.8.4639 · Cited by 66
Self-citationAssembly and analysis of the mouse immunoglobulin kappa gene sequence
Brekke, K. M., & Garrard, W. T. (2004) · Immunogenetics · doi:10.1007/s00251-004-0659-0 · Cited by 71
Analysis of the Bruton's tyrosine kinase gene promoter reveals critical PU.1 and SP1 sites
Himmelmann, A., Thevenin, C., Harrison, K., & Kehrl, J. (1996) · Blood · doi:10.1182/blood.v87.3.1036.bloodjournal8731036 · Cited by 65
Autocrine Induction of the Human Pro-IL-1β Gene Promoter by IL-1β in Monocytes
Toda, Y., Tsukada, J., Misago, M., Kominato, Y., Auron, P. E., & Tanaka, Y. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1984 · Cited by 66
Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand
Mages, H. W., Hutloff, A., Heuck, C. J., Büchner, K., Himmelbauer, H., Oliveri, F., & Kroczek, R. A. (2000) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(200004)30:4<1040::aid-immu1040>3.0.co;2-6 · Cited by 195
BSAP Can Repress Enhancer Activity by Targeting PU.1 Function
Maitra, S., & Atchison, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.6.1911-1922.2000 · Cited by 64
“BSAP as well as c-fos, c-jun, Pip, CREM, ATF1, E2A, YY1, and SP1 (7, 23, 31, 45, 48, 49, 51 , 52, 56, 59).”
Self-citationReview: The Role of IRF-4 in B and T Cell Activation and Differentiation
Pernis, A. B. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452728 · Cited by 68
Murine Macrophage Mannose Receptor Promoter Is Regulated by the Transcription Factors PU.1 and SP1
Eichbaum, Q., Heney, D., Raveh, D., Chung, M., Davidson, M., Epstein, J., & Ezekowitz, R. A. B. (1997) · Blood · doi:10.1182/blood.v90.10.4135 · Cited by 62
Ernst, P., Hahm, K., & Smale, S. T. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.5.2982 · Cited by 65
Bellon, T., Perrotti, D., & Calabretta, B. (1997) · Blood · doi:10.1182/blood.v90.5.1828 · Cited by 62
Regulation of IFN Consensus Sequence Binding Protein Expression in Murine Macrophages
Kantakamalakul, W., Politis, A. D., Marecki, S., Sullivan, T., Ozato, K., Fenton, M. J., & Vogel, S. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7417 · Cited by 61
Li, A. C., Guidez, F. R. B., Collier, J. G., & Glass, C. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.5389 · Cited by 60
Octamer Binding Factors and Their Coactivator Can Activate the Murine PU.1 (spi-1) Promoter
Chen, H.-M., Zhang, P., Radomska, H. S., Hetherington, C. J., Zhang, D.-E., & Tenen, D. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15743 · Cited by 59
Multiple motifs regulate the B-cell-specific promoter of the B29 gene.
Omori, S. A., & Wall, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11723 · Cited by 60
Huang, W., Horvath, E., & Eklund, E. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607760200 · Cited by 58
Phorbol ester-stimulated phosphorylation of PU.1: association with leukemic cell growth inhibition
Carey, J., Posekany, K., deVente, J., Pettit, G., & Ways, D. (1996) · Blood · doi:10.1182/blood.v87.10.4316.bloodjournal87104316 · Cited by 58
Grant, P. A., Arulampalam, V., Ährlund‐Richter, L., & Pattersson, S. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.17.4401 · Cited by 59
A Developmentally Modulated Chromatin Structure at the Mouse Immunoglobulin κ 3′ Enhancer
Roque, M. C., Smith, P. A., & Blasquez, V. C. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.6.3138 · Cited by 59
“The observed footprints are consistent with methylation interference data characterizing PU.1–NF-EM5 interactions with DNA in vitro (59) and suggest that these factors bind E39 as early as the pro-B-cell stage.”
BackgroundInfluentialInvolvement of the Ets Family Factor PU.1 in the Activation of Immunoglobulin Promoters
Schwarzenbach, H., Newell, J. W., & Matthias, P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.898 · Cited by 57
Hiramatsu, R., Akagi, K., Matsuoka, M., Sakumi, K., Nakamura, H., Kingsbury, L., David, C., Hardy, R. R., Yamamura, K.-I., & Sakano, H. (1995) · Cell · doi:10.1016/0092-8674(95)90138-8 · Cited by 45
Liu, J., & Ma, X. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602059200 · Cited by 56
Bosselut, R., Levin, J., Adjadj, E., & Ghysdael, J. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.22.5184 · Cited by 56
Regulation of gene expression at early stages of B-cell differentiation
Hagman, J. R., & Grosschedl, R. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90095-7 · Cited by 59
Polack, A., Feederle, R., Klobeck, G., & Hörtnagel, K. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06069.x · Cited by 54
Rieske, P., & Pongubala, J. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007482200 · Cited by 54
Self-citationGangenahalli, G. U., Gupta, P., Saluja, D., Verma, Y. K., Kishore, V., Chandra, R., Sharma, R. K., & Ravindranath, T. (2005) · Stem Cells and Development · doi:10.1089/scd.2005.14.140 · Cited by 53
ERM, a PEA3 Subfamily of Ets Transcription Factors, Can Cooperate with c-Jun
Nakae, K., Nakajima, K., Inazawa, J., Kitaoka, T., & Hirano, T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23795 · Cited by 53
Arguello, M., Sgarbanti, M., Hernandez, E., Mamane, Y., Sharma, S., Servant, M. J., Lin, R., & Hiscott, J. B. (2003) · Oncogene · doi:10.1038/sj.onc.1206270 · Cited by 63
“…cells) and it regulates B-cell-specific genes including the m heavy chain (Nelsen et al., 1993; Rao et al., 1997), the Ig light chains (l and k) (Pongubala et al., 1992; Eisenbeis et al., 1993), Iga (Feldhaus et al., 1992), Igb (Omori and Wall, 1993), Bruton’s Tyrosine kinase (Btk) (Muller et…”
BackgroundInfluentialSpi-C, a Novel Ets Protein That Is Temporally Regulated during B Lymphocyte Development
Bemark, M., Mårtensson, A., Liberg, D., & Leanderson, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.10259 · Cited by 53
Quang, C. T., Wessely, O., Pironin, M., Beug, H., & Ghysdael, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.18.5639 · Cited by 58
Analysis of Gene Expression and Ig Transcription in PU.1/Spi-B-Deficient Progenitor B Cell Lines
Schweitzer, B. L., & DeKoter, R. P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.144 · Cited by 52
PU.1/Spi-B Regulation of c-rel Is Essential for Mature B Cell Survival
Hu, C., Rao, S., Ramírez‐Bergeron, D. L., Garrett‐Sinha, L. A., Gerondakis, S., Clark, M. R., & Simon, M. C. (2001) · Immunity · doi:10.1016/s1074-7613(01)00219-9 · Cited by 57
Fisher, R. C., Olson, M. C., Pongubala, J. M. R., Perkel, J. M., Atchison, M. L., Scott, E. W., & Simon, M. C. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4347 · Cited by 49
Self-citationStage-Specific Modulation of IFN-Regulatory Factor 4 Function by Krüppel-Type Zinc Finger Proteins
Gupta, S., Anthony, A., & Pernis, A. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.6104 · Cited by 49
“1, IRF-4 can act as a transactivator of the Igk- and l-light chain enhancers and the CD20 promoter (1, 8, 9).”
BackgroundMethodAhne, B., & Strätling, W. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32378-5 · Cited by 49
Bednarski, J. J., Pandey, R., Schulte, E., White, L. S., Chen, B.-R., Sandoval, G. J., Kohyama, M., Haldar, M., Nickless, A., Trott, A., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151048 · Cited by 52
“The pre–BCR induces expression of IRF4, which, together with PU.1, binds the 3′ Igk enhancer to promote Igk germline transcription and rearrangement (Pongubala et al., 1992; Johnson et al., 2008; Clark et al., 2014).”
BackgroundTranscriptional Control of Mature B Cell Fates
Wang, H., Morse, H. C., & Bolland, S. M. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.04.011 · Cited by 50
The ETS Family of Transcriptional Regulators
Ghysdael, J., & Boureux, A. (1997) · Oncogenes as Transcriptional Regulators · doi:10.1007/978-3-0348-8889-9_2 · Cited by 48
Lundgren, M., Ström, L., Bergquist, L., Skog, S., Heiden, T., Stavnezer, J., & Gronowicz, E. S. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250736 · Cited by 47
PU.1-c-Jun interaction is crucial for PU.1 function in myeloid development
Zhao, X., Bartholdy, B., Yamamoto, Y., Evans, E. K., Alberich-Jordà, M., Staber, P. B., Benoukraf, T., Zhang, P., Zhang, J., Trinh, B. Q., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03888-7 · Cited by 46
Batista, C. R., Li, S. K. H., Xu, L. S., Solomon, L. A., & DeKoter, R. P. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601709 · Cited by 49
“PU.1 and Spi-B interact interchangeably with IRF4 or IRF8 to regulate genes containing ETS-IRF composite elements (EICEs) (48).”
BackgroundInfluentialRao, S., Matsumura, A., Yoon, J., & Simon, M. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.11115 · Cited by 47
Zhang, C., Gadue, P., Scott, E., Atchison, M., & Poncz, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.42.26236 · Cited by 48
Self-citationTranscriptional Regulation of Mouse μ Opioid Receptor Gene by PU.1
Hwang, C. K., Kim, C. S., Choi, H. S., McKercher, S. R., & Loh, H. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400755200 · Cited by 46
Self-citationJudde, J. G., & Max, E. E. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.11.5206 · Cited by 45
Mullick, J., Anandatheerthavarada, H. K., Amuthan, G., Bhagwat, S. V., Biswas, G., Vijayasarathy, C., BHAT, N. K., Reddy, S. E. P., Rao, V. N., & Avadhani, N. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100671200 · Cited by 46
Ortiz, M. A., Light, J., Maki, R. A., & Assa-Munt, N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2740 · Cited by 44
Self-citationZápražná, K., & Atchison, M. L. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.05989-11 · Cited by 50
Self-citationRao, S., Garrett‐Sinha, L. A., Yoon, J. W., & Simon, M. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.34245 · Cited by 55
Metadata
- Authors
- Pongubala, J. M., Nagulapalli, S., Klemsz, M. J., McKercher, S. R., Maki, R. A., & Atchison, M. L.
- Affiliations
- University of Pennsylvania (US)
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1992-01
- Volume
- 12
- Issue
- 1
- Pages
- 368-378
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC364131
- OpenAlex
- W1909754239
- Cited by
- 354
- References
- 48
- Citations by year
- 2025: 2 · 2023: 1 · 2022: 6 · 2020: 4 · 2019: 2 · 2018: 2 · 2017: 6 · 2016: 5 · 2015: 4 · 2014: 6 · 2013: 1 · 2012: 7
- FWCI
- 11.00
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ai030656-08)
- National Institute of General Medical Sciences (R01GM042415)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- PU.1, enhancer activity, transcription factor binding sites, protein-protein interaction, PEST sequence, DNA binding specificity
- MeSH terms
- Base Sequence, Binding Sites, Cell Line, DNA, DNA-Binding Proteins, Electrophoresis, Polyacrylamide Gel, Enhancer Elements, Genetic, Immunoglobulin kappa-Chains, Molecular Sequence Data, Nuclear Proteins, Organ Specificity, Transcription Factors, Retroviridae Proteins, Oncogenic, Mutagenesis, Site-Directed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.